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High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea 
and premenstrual syndrome in adolescents 
 
Abstract 
Vitamin D has a crucial role in female reproduction, possibly through its effects on calcium 
homeostasis, cyclic sex steroid hormone fluctuations, or neurotransmitter function. We have 
assessed the effects of vitamin D supplementation on dysmenorrhea and premenstrual 
syndrome (PMS) in adolescents. In this study, 897 adolescent girls living in Mashhad and 
Sabzevar, Iran, received 9 high-dose vitamin D supplements (as 50000 IU/ week of 
cholecalciferol) and were followed up over 9 weeks. We evaluated the effect of vitamin D 
supplementation on individuals in 4 categories: those with only PMS; individuals with only 
dysmenorrhea; subjects with both PMS and dysmenorrhea and normal subjects. The 
prevalence of PMS after the intervention fell from 14.9% to 4.8% (P<0.001). Similar results 
were also found for the prevalence of subjects with dysmenorrhea (35.9% reduced to 32.4%), 
and in subjects with both PMS and dysmenorrhea (32.7% reduced 25.7%). Vitamin D 
supplementation was associated with a reduction in the incidence of several symptoms of 
PMS such as backache and tendency to cry easily as well decrement in pain severity of 
dysmenorrhea (P<0.05). High dose vitamin D supplementation can reduced the prevalence of 
PMS and dysmenorrhea as well has positive effects on the physical and psychological 
symptoms of PMS. 
Key Words: Vitamin D supplementation, Menstrual cycle, Premenstrual syndrome, 
Dysmenorrhea  
 





Adolescence is a time of great physical and psychological change. Menstrual disorders are 
common and may add further disruption during this difficult stage for adolescents and their 
families[1]. Immaturity of the hypothalamus-pituitary-ovarian axis and disturbances in 
menstrual cycle are common through this phase of life. Approximately 75% of late 
adolescent girls experience some menstrual disorders [2]. Heavy menstrual bleeding, painful, 
irregular, and delayed are primary reasons for physician office visits, as well as 
dysmenorrhea known as pelvic pain or cramps is the main reason for school absenteeism 
among adolescents girls[2, 3].  A variation in mood and physical symptoms can take place 
several days to 2 weeks before menstruation, restricted to the luteal phase of the menstrual 
period, and gradually abate following the onset of menses[4, 5]. These symptoms include 
depression, irritability, tension, fatigue, sleep disturbances, somatic complaints such as 
abdominal cramping, and headache[5]. This phenomenon is known as the premenstrual 
syndrome (PMS). Epidemiological studies report that as many as 80% - 90% of women 
experience PMS[6]. PMS and dysmenorrhea significantly reduce the quality of life in all 
aspects in adolescent girls during menstruation[7]. 
Vitamin D has a critical role in female reproduction; the vitamin D receptor is expressed in 
ovarian tissue, endometrium, fallopian tube epithelial cells, decidua and placenta [8, 9]. It has 
also been reported that vitamin D reduces the production of prostaglandins [10]. Previous 
studies have assessed the role of vitamin D in preventing and/ or treating mood and 
gynecologic disorders that share common features with PMS [11]. In a sub-study within the 
prospective Nurses’ Health Study II (NHSII), a high dietary intake of vitamin D was related 




related to a significant 31% lower risk [12]. Several studies have reported an inverse 
association between serum vitamin D levels and risk of depression, fibromyalgia, 
dysmenorrhea, and uterine fibroids [10, 13-17]. But, it remains unclear whether vitamin D 
therapy may be useful for preventing and/or treating of dysmenorrhea or PMS. 
We have previously reported that vitamin D supplementation has a beneficial effect on 
cardio-metabolic profile, systemic inflammation and mood/emotional function in adolescents 
[9, 18, 19]. We have also recently reported that adolescent girls with dysmenorrhea have 
significantly more depression, aggression and sleep disorders compared with the normal 
subjects [20]. In this current study we aimed to assess the effect of supplementation with high 
dose vitamin D on menstrual problems, dysmenorrhea as well as PMS and associated 
symptom in adolescents. 
Methods  
Participants 
This was a prospective, interventional study with one treatment group over 9 weeks, and was 
conducted from January through April 2015 in the cities of Mashhad and Sabzevar, in Iran, as 
previously described [19, 21]. Briefly, participants were recruited from 6 geographical areas 
of these cities, using a cluster randomization method. Exclusion criteria included: any 
inflammatory or autoimmune disease, tumor, renal or hepatic failure, cardiovascular disease, 
chronic lung disorder, diabetes, asthma, multiple sclerosis (MS), polycystic ovary syndrome 
(PCOS), pelvic organ pathology chronic bronchitis, fibromyalgia, malabsorption, metabolic 
bone disease and thyroid, or parathyroid illness. Also, those participants who were receiving 




months before intervention were omitted. Of the 940 adolescents met the inclusion criteria,, 
897 girls had the menarche one year before the intervention and were entered into the present 
study. Subjects were assigned to receive 9 capsules containing 50000IU of vitamin D for 9 
weeks. The Ethics Committee of Mashhad University of Medical Sciences (MUMS) 
approved the study, and written informed consent was obtained for all participants and their 
parents/ guardian.  
 
Evaluation of menstrual pattern and menstruation associated symptoms  
Menstrual pattern, common menstruation associated psychovegetative symptoms, 
dysmenorrhea and PMS status were evaluated before and after vitamin D therapy using 
standard questionnaires, as previously described [20]. In brief, answers to questions regarding  
menstrual patterns within the last 2 cycles of menstruation were gathered. These included: 
menstrual cyclicity, cycle duration, quantity of blood loss, and days of flow length. 
Amount of menstrual flow was defined regarding to the number of pad being suffice for 
protection during the menstrual periods: Little (less than 1 fully soaked pad or of panty liner), 
moderate (1-3 fully soaked pad) and Heavy (4 or more fully soaked pads a day for protection) 
[22].  
Dysmenorrhea was characterized by abdominal pain, or cramping associated to menstrual 
bleeding and individuals rated their pains using a scale that varied from a painless (score of 0) 
to mild (score of 1), moderate (score of 2), severe (score of 3), very severe (score of 4) and a 




Participants were instructed to answer questions about the most frequent physiological and 
psychological symptoms that occur before the menses including: leg ache, backache, 
diarrhea, nausea, vomiting, fatigue, irritability, palpitation, appetite changes, poor sleep, 
energy depletion, decrease interest, feeling sad or blue, loss of concentration and tendency to 
cry easily. 
Those having at least two symptoms, one physical and one psychological symptom were 
diagnosed as PMS, while those with one symptom or no symptoms were regarded as not 
having PMS [24]. For exact assessment, participants were also classified into four categories 
as follows: subjects with only PMS, subjects with only dysmenorrhea, those suffered from 
both PMS and dysmenorrhea, as well as normal subjects. 
Laboratory measurement 
An electrochemiluminescence (ECL) method was used for the measurement of serum 25 
(OH) vitamin D. Serum 25 (OH) vitamin D was categorized based on the accepted cutoff 
values (nmol/L): serum 25 (OH) vitamin D levels <50 deficiency, 50-74.9 insufficiency and 
>75 sufficiency [25]. 
Statistical analysis 
McNemar or Cochran's Q tests and paired sample t-test were used to compare variables before and 
after supplementation. All data are expressed as frequency, percent and mean±SD. P < 0.05 was 
considered statistically significant. Statistical analyses were conducted with SPSS version 17 (SPSS 






A total of 897 girls were analyzed. All the study population was unmarried at the time of the 
study. The mean age of the participants was 14.72±1.50 years (range, 12-18 years) and their 
mean age at menarche was 12.57±1.19 years, and occurring between 9 and 17 years. No 
adverse effects were observed in those who taking the high dose vitamin D supplement. 
Serum levels of 25 (OH) vitamin D increased significantly by the end of intervention period, 
compared to the baseline levels (22.7±22.6 nmol/L vs. 89.9±38.3 nmol/L, p<0.001). The 
prevalence of deficiency, insufficient and sufficient serum levels of 25OH vitamin D was 
85.3%, 9.7% and 4.9% in participants at the baseline, respectively. 
After supplementation, the prevalence of vitamin D deficiency was reduced to 16.6%, while 
insufficiency and sufficiency levels were 19.9% and 63.5% respectively (p<0.001).  
A normal duration of menstrual flow was seen in 81.4% of participants. After intervention 
this increased to 85.5%. At baseline, 23.6% had short length cycle, 71.8% had normal cycle, 
and 4.7% had long length cycle. After supplementation, the number of subjects with a normal 
cycle increased to 78%, while the number of girls with short length cycle and long length 
cycle decreased to 18.0% and 4.0% respectively (p=0.015). Furthermore, subjects with 
moderate menstrual flow increased post therapy but this value did not reach statistically 
significance (Table1). 
All 15 individual symptoms of PMS were analyzed to determine the efficacy of intervention. 
Symptom of backache, nausea, vomiting and diarrhea decreased after intervention, but only 
the reduction in backache was statistically significant (P<0.05). There were no significant 
differences in psychological symptoms, except for tendency to cry easily which suggests a 




before each menses was experienced by 31.8% of woman. After intervention, 22.8% still 
showed this symptom (Table 1). 
At baseline, the prevalence of subjects with PMS alone was 14.9%, while this value after 
intervention was decreased to 4.8% (P<0.001). Similar results were also found for the 
prevalence of subjects with only dysmenorrhea (35.9% reduced to 32.4%), both PMS and 
dysmenorrhea (32.7% reduced to 25.7%), while normal cases increased from 16.5% to 37.1% 
after therapy (P<0.001). 
The number of subjects with dysmenorrhea fell post supplementation and pain severity of 
dysmenorrhea had relief after the 9-week intervention. Furthermore, the number of cases who 
used medication for pain relief fell significantly following supplementation (Table 3). 
Discussion 
To our knowledge, this is the first study investigating the effect of a supplementation with 
very high doses of vitamin D on menstrual pattern, primary dysmenorrhea and PMS 
concomitantly in large population of adolescents. Taking a high-dose of vitamin D3 (50000 
IU/ weekly) is recommended for preventing and treatment of vitamin D deficiency [26]. In the 
current study, we administrated nine high-dose vitamin D pearls (50000 IU cholecalciferol /weekly) 
during a period of nine weeks. We have demonstrated a significant association between vitamin 
D therapy and improvement of PMS and dysmenorrhea among adolescents. In line with our 
observation, a placebo-controlled study of calcium (500 mg) plus vitamin D (200 mg) 
supplementation and PMS, showed that supplementation was associated with a reduced 
severity of symptom of PMS [27]. Bertone-Johnson in 2009 discussed this issue and claimed 
that intake of low dietary vitamin D has been related to the development of PMS [14]. 




affecting calcium levels, fluctuation of cyclic sex steroid hormone, and/or neurotransmitter 
function [14, 28, 29]. Vitamin D fluctuations across the menstrual cycle along with 
alterations in estradiol at ovulation and through the luteal phase have been reported in a 
number of but not all studies [29]. Thys-Jacobs and Alvir observed serum 25(OH) vitamin D 
concentrations to be significantly lower in PMS subjects across 3 phases of the menstrual 
cycle, although 1,25(OH) vitamin D concentrations were non-significantly higher in PMS 
subjects at all phases compared to control[30]. Results from another larger study showed that 
non-significantly higher use of vitamin D supplements (41% vs. 30%) among women with 
premenstrual dysphoric disorder compared to symptom-free controls[30].Over 100 different 
menstrual symptoms are associated with PMS[31], and the unique symptoms affected women 
may differ considerably. Similarly, associations of vitamin D with specific symptoms may 
vary. In the present analysis, vitamin D supplementation can significantly decrease incidence 
of backache and tendency to cry easily (P < 0.05) and possibly nausea, loss of concentration, 
and lack of energy (P ≤ 0.2). Despite the low rates of symptoms reduction in our study, the 
reduction in PMS incidence is both statistically and clinically significant. Regarding to the 
importance of PMS in the overall quality of life for each women, even low reduction rate can 
be considered important. 
The majority of adolescents with dysmenorrhea use self-medication; few consult health care 
providers [32]. Based on our finding, high dose vitamin D supplementation can reduce the 
prevalence and pain intensity of dysmenorrhea. Consistent with our result, trials in Iran [33] 
and Italy [10] have demonstrated that the use of a single dose oral cholecalciferol(300000 




of severe primary dysmenorrhea, however this effect was non-significant where the pain 
intensity was moderate [33].  
In another clinical trial on 60 women with primary dysmenorrhea administration of 50000 
unit oral vitamin D for 8 weeks decreased significantly pain severity versus control 
group[34]. But, Zarei et al found that supplementation with combination of calcium-vitamin 
D did not significantly decrease pain severity [35]. It may be due to the absence of vitamin D-
alone group and its assignment may have no further effect when there is a sufficient calcium 
supplementation. 
Prolonged menstrual bleeding usually occurs early after the onset of menarche because of 
anovulatory cycles. In the present study, a reduction in the number of cases with a long 
menstrual cycle was associated with vitamin D supplementation, but this effect was not 
significant.  
We have demonstrated that vitamin D supplementation significantly affects the duration of 
menstrual cycle among participants. The prevalence of cycles longer than 35 days or 
oligomenorrhea ranged from 8% to 22% in various studies. Although infrequent cycling is 
not generally associated with adverse health outcomes, irregular cycles or amenorrhea may 
be associated with infertility, which puts the social burden of childlessness on women 
specially in developing countries [36]. Jukic et al have reported that low plasma levels of 
25(OH) D are associated with a high risk of having irregular cycles [37]. In another study, an 
increase in 25(OH)D was related with a low odds of long menstrual cycles [38]. This 
discrepancy between these two reports may be as a result of different population samples; 




Menorrhagia or excessive heavy or prolonged menstrual blood loss, affect 10–15% of female 
during their lifetime [36] which may be caused by anatomical gynecological pathology, 
hormonal variations and medical disorders such as hypothyroidism[39]. Congenital and 
acquired disorders of homeostasis, thrombocytopenia and inherited bleeding disorders, such 
as von Willebrand Disease, platelet function defects are the common causes of menorrhagia 
in adolescents[40]. Whilst we found that vitamin D supplementation reduced the number of 
subjects with heavy menstrual flow, this was not statistically significant. 
The high dose vitamin D supplementation improved serum concentration of 25(OH) vitamin 
D in our study subjects. Taking 50000 IU-vitamin D for 8 weeks has been recommended for 
the treatment of vitamin D deficiency [26]. Similar results were observed for the effect of 
vitamin D supplementation on serum 25 OH) vitamin D in previous studies [41-43]. 
No side effects related to the vitamin D supplement was observed among participants. Some 
limitations need to be considered in the explanation of our finding. We were unable to 
include a control group (non-supplemented) in the current study because this was not 
approved by our Ethics Committee. Furthermore, there is a potential for recall bias, as all of 
the variables related to menstruation issue were taken using a recall method. According to the 
studies conducted on supplementation to treat PMS symptoms, several confounding factors 
may influence the results. These factors include age, education level, and stress, although we 
adjusted their possible effects. Moreover, we were unable to assess the long term effect of 
vitamin D supplementation. The available evidence suggest that vitamin D supplementation 
can have positive effects on dysmenorrhea and its pain severity as well as PMS and related 
symptoms. Therefore these positive findings have renewed optimism that vitamin D 




large-scale randomized controlled trials are needed to confirm our finding and evaluate the 
longer term effect of supplementation. 
Geolocation information 
Iran also known as Persia is a sovereign state in Western Asia. It is bordered to the northwest 
by Armenia, the Republic of Azerbaijan, and the Azerbaijani exclave of Nakhchivan; to the 
north by the Caspian Sea; to the northeast by Turkmenistan; to the east by Afghanistan and 
Pakistan; to the south by the Persian Gulf and the Gulf of Oman; and to the west by Turkey 
and Iraq. Mashhad is the second most populous city in Iran and capital of Razavi Khorasan 
Province. It is located in the northeast of the country.  
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Table 1. Effects of vitamin D supplementation on menstrual pattern and common menstruation associated 
psychovegetative symptoms in adolescent girls 
 Before supplementation After supplementation P value 
Average days of bleeding, n (%) 
Short bleeding periods( 4 days) 46(5.1) 40(4.5) 
0.549 Normal periods (4-7 days) 730(81.4) 767(85.5) 
Long periods( >7 day) 121(13.5) 90(10.0) 
Duration of the menstruation cycle, n (%) 
<21 days 212(23.6) 161(18.0) 
0.015 21-35 days 643(71.7) 700(78.0) 
>35 days 42(4.7) 36(4.0) 
Amount of menstrual flow, n (%) 
Little 208(23.2) 198(22.1) 
0.434 Moderate 675(75.2) 688(76.7) 
Heavy 14(1.6) 11(1.2) 
Menstruation-associated symptoms, n (%) 
Leg ache 172(19.2) 174(19.5) 0.99 
Backache 538(60.0) 492(54.8) 0.002 
Nausea 73(8.1) 63(7.0) 0.185 
Vomiting 26 (2.9) 20(2.2) 0.210 
Diarrhea 28(3.1) 25(2.8) 0.70 
Appetite changes 4(0.4) 5(0.5) 0.99 
Irritability 57(6.4) 54(6.0) 0.99 
Fatigue 86(9.6) 67(7.5) 0.219 
Palpitation 84(9.4) 85(9.5) 0.99 
Energy depletion 89(9.9) 73(8.1) 0.185 
Poor sleep 11(1.2) 5(0.5) 0.90 
Feeling sad or blue 74(8.2) 66(7.4) 0.693 
Decrease interest 111(12.4) 108(12.0) 0.937 
Loss of concentration 139(15.5) 117(13.1) 0.146 
Tendency to cry easily 285(31.8) 205(22.8) 0.001 


















Table 2. Effects of vitamin D supplementation on dysmenorrhea and PMS subjects 
P value 






231(25.7) 293(32.7) PMS+Dysmenorrhea 
291(32.4) 322(35.9) Only dysmenorrhea 
43(4.8) 134(14.9) Only PMS 
332(37.1) 148(16.5) Normal 












Dysmenorrhea, yes 617(68.8) 565(63.0) 0.002 
Mild 85(9.5) 99(11) 
0.043 
Moderate 187(20.8) 170(19.0) 
Severe 162(18.1) 145(16.2) 
Very severe 110(12.3) 81(9.0) 
Worst 73(8.1) 70(7.8) 
Use of medication for relief pain 316(35.2) 258(28.8) 0.009 
Using McNemar or Cochran's Q tests 
 
 
 
 
 
 
 
 
